logo
Select company
Select metric
$ 34.19MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
47
Sector
81
Industry
66
History
10
$ 11.93Close
$ 10.13 - $ 21.29 52-Week Range
Ticker Information

Ticker

NRC

Company Name

NATIONAL RESEARCH CORP

Sector

Healthcare

Industry

Health Information Services

Exchange

NASDAQ

NATIONAL RESEARCH CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRC - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 6.35M$ 27.84M$ 34.19M
3/31/2025$ 6.12M$ 35.11M$ 41.22M
12/31/2024$ 6.02M$ 35.28M$ 41.31M
9/30/2024$ 5.94M$ 37.42M$ 43.35M
6/30/2024$ 5.94M$ 39.61M$ 45.56M
3/31/2024$ 5.95M$ 40.37M$ 46.32M
12/31/2023$ 5.9M$ 40.82M$ 46.72M
9/30/2023$ 5.84M$ 38.84M$ 44.69M
6/30/2023$ 5.59M$ 39.78M$ 45.37M
3/31/2023$ 5.36M$ 41.53M$ 46.88M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NATIONAL RESEARCH CORP's latest trailing twelve months (TTM) EBITDA stands at $ 50.68M.
  • Over the past 5 years, NATIONAL RESEARCH CORP's average EBITDA has been $ 48.4M.
  • The median EBITDA for NATIONAL RESEARCH CORP during this period was $ 48.09M
  • NATIONAL RESEARCH CORP reached its highest EBITDA over the past 5 years at $ 56.66M.
  • The lowest EBITDA recorded by NATIONAL RESEARCH CORP in the same timeframe $ 34.19M

NATIONAL RESEARCH CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SPOK : SPOK HOLDINGS INC $ 26.41MOPRX : OPTIMIZERX CORP $ 1.04MCTMX : CYTOMX THERAPEUTICS INC $ 54.08MTALK : TALKSPACE INC $ -401KSLP : SIMULATIONS PLUS INC $ -60.34MRXST : RXSIGHT INC $ -28.93MPACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC $ -112.13MAIRS : AIRSCULPT TECHNOLOGIES INC $ 4.04MARCT : ARCTURUS THERAPEUTICS HOLDINGS INC $ -72.27MLFCR : LIFECORE BIOMEDICAL INC $ -8.81M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for NATIONAL RESEARCH CORP is calculated as follows: EBIT [ $ 44.8M ] + DepAmor [ $ 5.88M ]
(=) EBITDA [ $ 50.68M ]

NRC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ 34.19M

Minimum

Jun 30, 2025

$ 56.66M

Maximum

Dec 31, 2021

$ 48.4M

Average

$ 48.09M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 166.93M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.76M
median$ 8.83M
std$ 166.93M